← Back to all trials
Not Yet Recruiting
NCT07796165
SNIP follow-on Case Series Using v3 Device
Conditions: Ankyloglossia
Sex: All
Ages: 1 Week – 12 Weeks
Healthy volunteers: No
Phase: NA
Enrollment: 6
Sponsor: Europa Life Sciences Limited
Location: Tunbridge Wells Hospital Pembury Royal Tunbridge Wells
Summary
Case series of infants with anterior ankyloglossia being treated by the Sublingual Neonatal Incision Platform device
Eligibility Criteria
Inclusion Criteria:
* Ankyloglossia requiring intervention
Exclusion Criteria:
* Concomitant morphological variation in the oral cavity which could compromise frenotomy
* Blood dyscrasia
* Immunocompromise
Source: ClinicalTrials.gov (NCT07796165). StuddyBuddy aggregates publicly available trial information.